SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of DaVita Inc. – DVA

NEW YORK, NY / ACCESSWIRE / January 30, 2017 / Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. (“DaVita” or the “Company”) (NYSE: DVA). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether DaVita and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On January 6, 2017, the Wall Street Journal reported that DaVita had received subpoenas from federal prosecutors seeking “the production of information related to charitable premium assistance” in connection with DaVita’s ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis.

On this news, DaVita stock fell $2.41, or 3.66%, to close at $63.38 on January 9, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 453848